(Q34579668)

English

Results of treatment of children with refractory anaemia with excess blasts (RAEB) and RAEB in transformation (RAEBt) in Great Britain 1990-99.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

Europe PubMed Central

Results of treatment of children with refractory anaemia with excess blasts (RAEB) and RAEB in transformation (RAEBt) in Great Britain 1990-99. (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

refractory anemia

1 reference

based on heuristic

inferred from title

author name string

David K H Webb

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Sarah J Passmore

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Ian M Hann

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Georgina Harrison

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Keith Wheatley

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Judith M Chessells

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

language of work or name

0 references

publication date

1 April 2002

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

117

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

33-39

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Proposals for the classification of the myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03369.X

21 January 2018

Myelodysplastic syndrome in children: differentiation from acute myeloid leukemia with a low blast count.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03369.X

21 January 2018

The role of intensive AML-specific therapy in treatment of children with RAEB and RAEB-t.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03369.X

21 January 2018

The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03369.X

21 January 2018

A population-based study of childhood myelodysplastic syndrome in British Columbia, Canada.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03369.X

21 January 2018

Myelodysplastic syndromes in children

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03369.X

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03369.X

21 January 2018

Treatment-related deaths during induction and first remission of acute myeloid leukaemia in children treated on the Tenth Medical Research Council acute myeloid leukaemia trial (MRC AML10). The MCR Childhood Leukaemia Working Party

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03369.X

21 January 2018

Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03369.X

21 January 2018

Outcome for children with relapsed acute myeloid leukaemia following initial therapy in the Medical Research Council (MRC) AML 10 trial. MRC Childhood Leukaemia Working Party

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03369.X

21 January 2018

A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03369.X

21 January 2018

Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03369.X

21 January 2018

Identifiers

10.1046/J.1365-2141.2002.03369.X

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34579668&oldid=1588248307"